Showing results (91-100 of 272) with videos related to
Sort By:
Pageof 28
The Oncologist|April 19, 2015
Comparative effectiveness of mitoxantrone plus prednisone versus prednisone alone in metastatic castrate-resistant prostate cancer after docetaxel failureAngela K Green, Robert W Corty, William A Wood, et al.Expert Opinion on Therapeutic Targets|September 22, 2010
HIF, hypoxia and the role of angiogenesis in non-small cell lung cancerAutumn L Jackson, Bing Zhou, William Y KimJournal of Pain and Symptom Management|October 23, 2020
Mortality Risk for Patients With Stage IV Cancer and Acute Illness HospitalizationLaura C Hanson, Natalie C Ernecoff, Kathryn L Wessell, et al.BJU International|December 12, 2013
Muscle-invasive bladder cancer: evaluating treatment and survival in the National Cancer Data BaseAngela B Smith, Allison M Deal, Michael E Woods, et al.BJU International|February 16, 2011
Regional lymph node status in patients with bladder cancer found to be pathological stage T0 at radical cystectomy following systemic chemotherapyMatthew G Kaag, Matthew I Milowsky, Guido Dalbagni, et al.The Journal of Clinical Investigation|August 24, 2018
Endogenous retroviral signatures predict immunotherapy response in clear cell renal cell carcinomaChristof C Smith, Kathryn E Beckermann, Dante S Bortone, et al.Urologic Oncology|February 26, 2013
Roadmap for the development of the University of North Carolina at Chapel Hill Genitourinary OncoLogy Database--UNC GOLDSarah A Gallagher, Angela B Smith, Jonathan E Matthews, et al.JCO Precision Oncology|September 11, 2020
Comprehensive Molecular Characterization of Urachal Adenocarcinoma Reveals Commonalities With Colorectal Cancer, Including a Hypermutable PhenotypeJordan Kardos, Sara E Wobker, Michael E Woods, et al.BJU International|July 16, 2011
Germline BRCA mutation does not prevent response to taxane-based therapy for the treatment of castration-resistant prostate cancerDavid J Gallagher, Angel M Cronin, Matthew I Milowsky, et al.Tumori|May 11, 2023
Electronic cigarette, or vaping, product use-associated lung injury (EVALI) in a patient with testicular cancer: A case reportJacob Stein, Hannah E Kay, Jeremy Sites, et al.Pageof 28